High Risk of Recurrence of Malignancy Noted in Four-day rATG Regimen After Allogeneic PBSCT From Matched Sibling Donors

Nan Wang(Nankai University), Dai‐Hong Liu(Chinese PLA General Hospital), Mingyu Jia(Chinese PLA General Hospital), Sai Huang(Chinese PLA General Hospital), Liping Dou(Zhejiang Chinese Medical University), Xiangshu Jin(Jilin University), Lingmin Xu(Chinese PLA General Hospital), Fei Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Haitao Wang(China South Industries Group (China)), Shu Fang(Peking University), Jishan Du(PLA Academy of Military Science)
Transplantation and Cellular Therapy
August 13, 2022
Cited by 4


Related Papers